News | July 06, 2022
Vaccizone selects Exothera for GMP manufacturing of its SARS?CoV?2 vaccine
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
_256_384.jpg){kind=logo}
Meets the growing need for US-based API solubility and bioavailability enhancement services
Govt committed to supporting pharma companies with industry-friendly policies
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
Lacosamide Injection is used to treat partial-onset seizures.
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
States were also strongly advised to strictly monitor epidemiological profile of admitted COVID patients
Subscribe To Our Newsletter & Stay Updated
